Please select the option that best describes you:

How are you dosing IVIG following BCMA CAR-T or bispecific antibodies in multiple myeloma?   

Do you only offer it for patients with a documented IgG < 400? Do you check the IgG at all, or are you doing primary prophylaxis?



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Agreed with this answer x1000 - especially because...
Sign in or Register to read more